Table 4.
Other PROs measures over 72-week study period
Baseline mean (SD) | Week 12 | Week 24 | Week 48 | Week 72 | ||
---|---|---|---|---|---|---|
| ||||||
Mean change from baseline (SD) | ||||||
BPI | N-value | 248 | 209 | 180 | 143 | 115 |
Intensity | 3.1 (2.42) | −0.6 (1.97) | −0.5 (2.13) | −0.2 (1.92) | −0.1 (1.91) | |
Interference | 2.9 (2.58) | −0.7 (2.20) | −0.2 (2.31) | 0.0 (2.15) | 0.1 (2.19) | |
BFI | N-value | 250 | 209 | 187 | 147 | 116 |
Fatigue level | 2.8 (2.47) | −0.2 (1.96) | −0.1 (2.12) | 0.4 (2.15) | 0.1 (2.08) | |
CHS-PCa | N-value | 251 | 209 | 189 | 148 | 118 |
Physical | 4.7 (1.35) | 0.3 (1.14) | 0.1 (1.31) | 0.0 (1.34) | 0.1 (1.44) | |
Emotional | 5.4 (1.46) | 0.3 (1.26) | 0.3 (1.49) | −0.0 (1.48) | 0.0 (1.57) |
BPI: Brief Pain Inventory; BFI: Brief Fatigue Inventory; CHS-PCa: Current Health Satisfaction in Prostate Cancer; SD: standard deviation.